Carpal Tunnel Syndrome, Energy Transfer Capacitative and Resistive Therapy
Conditions
Keywords
Carpal tunnel syndrome, TECAR therapy, median nerve CSA
Brief summary
Objective: The aim of this study was to evaluate the effect of Transfer Energy Capacitive and Resistive (TECAR) therapy on pain, symptom severity and function in patients diagnosed with carpal tunnel syndrome (CTS) based on clinical and electromyography (EMG) findings and to compare it with ultrasound therapy (US). Methods: A total of 42 patients aged between 18 and 65 years, were randomly divided into two groups; group 1, US therapy 5 minutes intermittently for 2 weeks, 5 times a week, for a total of 10 sessions, group 2 TECAR therapy 5 min capacitive (CAP) and 10 min resistive (RES), 3 days a week for 2 weeks, for a total of 6 sessions. Both groups received paraffin therapy and wrist orthosis. All Patients were evaluated using the Visual Analog Scale (VAS) for pain and paresthesia levels, the Boston Carpal Tunnel Questionnaire (BCTQ) for symptom severity and functional levels. Additionally, median nerve CSA was measured by ultrasound, at the baseline, post-treatment, first and third months.
Interventions
DEVICEUS therapy
3 MHz probe with a BTL brand device at a dose of 1.5 watts/cm2 for 5 minutes intermittently for 2 weeks, 5 times a week, for a total of 10 sessions.
DEVICETECAR
Transfer Energy Capacitative and Resistive Therapy
Sponsors
Ankara City Hospital Bilkent
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* 18 years of age and over * had pain and numbness in their hands for more than 3 months were evaluated * Patients diagnosed with mild and moderate CTS by EMG
Exclusion criteria
* metabolic, rheumatic, or neurological diseases that could affect the median nerve cross-sectional area (CSA) * patients who had previously undergone surgery on the wrist, * oncology patients, * pregnancy, * pacemakers.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale (VAS) | baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month | 0 min , 10 is maximum pain score |
| Boston Carpal Tunnel Questionnaire (BCTQ) | baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month | symptom severity on functional tasks (Symptom Severity Scale), involving 11 items, and the other one on function status properly (Functional Status Scale), involving 8 items. Both subscales of BCTQ are scored between 1 and 5, and higher scores illustrate a greater degree of disability. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Median nerve cross-sectional area (CSA) measurement | baseline (0 th day), after-treatment (15 th day), 1th month, 3rd month | Median nerve CSA was measured by ultrasound on axial view at the scaphoid-pisiform level which is a reliable measurement for CTS. Three measurements were taken for analysis and the average value was recorded |
Countries
Turkey (Türkiye)
Outcome results
None listed